FeesSafety
Pluang+

UK regulator begins review of Ultragenyx's gene therapy for rare Sanfilippo syndrome Type A

Market News
06 Nov 2026, 10:30 WIB
GlobeNewsWire
View Source
Bullish
UK regulator begins review of Ultragenyx's gene therapy for rare Sanfilippo syndrome Type A

Ultragenyx's Marketing Authorisation Application for rebisufligene etisparvovec, a gene therapy for Sanfilippo syndrome Type A, has been accepted for review by the UK MHRA. This rare genetic disorder causes severe neurological decline in children, with limited treatment options. The MHRA's acceptance initiates a formal scientific review, while Ultragenyx coordinates with NICE to align health technology assessment and potential NHS access. The therapy is already FDA-approved but remains investigational in the UK pending regulatory decisions.

Ultragenyx's gene therapy for Sanfilippo syndrome Type A is under regulatory review in the UK. For readers following health sector stocks, here is Pluang's market snapshot as of Nov 06, 2026 14:51 WIB: out of 150 priced US health stocks, 32 rose and 115 fell. Notable movers include WGS (GeneDx Holdings Corp) at USD 62.61, down 9.71%, BRKR (Bruker Corporation) at USD 57.61, down 9.69%, and CGC (Canopy Growth Corp) at USD 0.68, down 9.54%. Typical hold times range from 14 to 40 days, with mixed buy-sell order activity.

More News

Vallourec secures €750M multi-currency credit line, boosting investment-grade financial profile.

Vallourec secures €750M multi-currency credit line, boosting investment-grade financial profile.

Vallourec has signed a new €750 million multi-currency revolving credit facility (RCF) to replace its previous credit lines, improving its financial structure to align with an investment-grade profile. The new five-year credit line, with options to e...

Company Fundamentals
Bullish
2 hours ago
DNO ASA shares go ex-dividend Nov 6, paying NOK 0.375 per share on Nov 17.

DNO ASA shares go ex-dividend Nov 6, paying NOK 0.375 per share on Nov 17.

Norwegian oil and gas company DNO ASA announced its shares will trade ex-dividend starting November 6, 2026. Shareholders on record as of November 9 will receive a dividend of NOK 0.375 per share, payable around November 17. This dividend reflects th...

Company Fundamentals
Neutral
2 hours ago
Vallourec secures €750M revolving credit facility to strengthen its investment-grade financial profile

Vallourec secures €750M revolving credit facility to strengthen its investment-grade financial profile

Vallourec has signed a new €750 million multicurrency revolving credit facility (RCF) to replace its previous credit lines, improving its financial structure with better terms and lower costs. The five-year facility, coordinated by BNP Paribas and Na...

Company Fundamentals
Bullish
2 hours ago
Equinix opens SG6, a sustainable AI-focused data center in Singapore with advanced cooling and renewable energy.

Equinix opens SG6, a sustainable AI-focused data center in Singapore with advanced cooling and renewable energy.

Equinix has launched SG6, its sixth data center in Singapore, designed to support AI, high-performance computing, and data-heavy workloads. The facility features advanced liquid cooling and renewable energy systems, aiming for high efficiency and sus...

Market News
Bullish
5 hours ago
Bitcoin developer proposes "quantum landmines" to deter future quantum computer thefts by risking attackers' own BTC.

Bitcoin developer proposes "quantum landmines" to deter future quantum computer thefts by risking attackers' own BTC.

Bitcoin Core developer Cory Fields proposed a system called "quantum landmines" to protect wallets vulnerable to quantum computer attacks by requiring anyone spending such Bitcoin to post collateral equal to the coins' value. This collateral could be...

Protocol Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App